The Pacific Mesothelioma Center is Excited to Announce the Start of Its Patient Support Group!
The support group will allow mesothelioma patients to discuss treatment experience with other patients, how to overcome side effects, share stories, and to ask questions about this rare cancer. Mesothelioma is an aggressive cancer caused by exposure to asbestos with few treatment options. It affects approximately 3,000 individuals in the United States each year, one-third of whom are veterans who were exposed to asbestos during military service. The rarity of this cancer limits the scope of the public’s awareness and funding for research into better treatment options.
The mission of the PMC is to generate hope through research, support, and education. The Pacific Mesothelioma Center is engaged in groundbreaking research to develop next-generation immunotherapies. PMC researchers have discovered an innovative approach to convert human mesenchymal stem cells (MSCs) into potent immune-boosting treatments that will pave the way for an entirely new class of immunotherapies that could be effective against a wide variety of cancer types, including the most aggressive ones like mesothelioma.
If you are a mesothelioma patient interested in participating on the call, please contact Christina McSherry at (310)-478-4678 or by email at christinam@phlbi.org.
Christina McSherry
The Pacific Mesothelioma Center
(310)-478-4678
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.